Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
16.90
+0.87 (5.43%)
At close: Aug 18, 2026, 4:00 PM EDT
16.89
-0.01 (-0.06%)
Pre-market: Aug 19, 2026, 4:54 AM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $230.59 million as of August 19, 2026. Its market cap has increased by 159.31% in one year.
Market Cap
230.59M
Enterprise Value
76.06M
1-Year Change
159.31%
Ranking
Category
Stock Price
$16.90
ChartMarket Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $230.59M, a decrease of -5.34%. That is a compound annual growth rate of -0.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 230.59M | 259.20% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Niagen Bioscience | 242.64M |
| Protara Therapeutics | 235.20M |
| Arcturus Therapeutics Holdings | 233.35M |
| Cellectis | 229.89M |
| Precision BioSciences | 227.16M |
| Compugen | 225.44M |
| AN2 Therapeutics | 225.29M |
| Atrium Therapeutics | 219.64M |